bluebird bio (BLUE)
(Delayed Data from NSDQ)
$0.47 USD
-0.05 (-9.39%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $0.47 0.00 (-0.15%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.38 | 6.75% |
Earnings Summary
For their last quarter, bluebird bio (BLUE) reported earnings of -$0.42 per share, missing the Zacks Consensus Estimate of -$0.40 per share. This reflects a negative earnings surprise of 5.00%. Look out for BLUE's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.38 per share, reflecting a year-over-year increase of 42.42%.
Earnings History
Price & Consensus
Zacks News for BLUE
Y-mAbs Therapeutics, Inc. (YMAB) Reports Q2 Loss, Misses Revenue Estimates
BLUE: What are Zacks experts saying now?
Zacks Private Portfolio Services